B-cell growth factor I [BCGF I or B-cell-stimulating factor, provisional 1 (BSFpl)] has been defined as a T-cell-derived lymphokine that acts as a co-stimulator of polyclonal B-cell growth in B cells cultured with anti-IL, anti-6, or anti-Ig. Based on a number of studies it has been suggested that anti-Ig induces cell enlargement, entry into the G1 phase of the cell cycle, and expression of receptors for BSFp1. (2,3). When cultured in the presence of both anti-Ig and BSFpl, resting Go B cells proceed through G1 and enter the G2/S phase of the cell cycle. It has been suggested that BSFp1 acts during the first 12 hr of coculture with anti-, (1). B-cell growth is affected by three other cytokines: (i) interleukin 1 (IL-1), a macrophage-derived factor that enhances entry of B cells into S phase after their treatment with anti-,u and BSFpl (4, 5); (ii) BCGF II, a T-cell-derived late-acting BCGF that does not costimulate with anti-,u (3, 6); and (iii) interleukin 2 (IL-2), a T-cell-derived factor that acts on Bcell blasts (5,7,8).Recent studies by Noelle et al. (9) and Roehm et al. (10) have demonstrated that the BSFpl-containing SN (9, 10) or highly purified BSFp1 (9) induces a selective increase in the expression of Ia antigens on small, resting B cells. Such treated B cells do not enter the cell cycle (9). These results indicate that BSFpl can function as a differentiation factor and that receptors for BSFp1 are present on resting B cells. Hence, the results are incompatible with models in which BSFp1 receptors are only expressed after the cells have been induced by anti-,u to enlarge and enter G, (1,5 Cell Culture Conditions. Sorted B cells were cultured as described (12). In addition, small Thy-1.2-cells were cultured at 50,000 per well for 24 hr (phase 1) with either PK 7.1 SN, BSFpl, or anti-8-Sepharose. Cells were then centrifuged at 300 rpm for 3 min to remove the anti-8-Sepharose or at 1000 rpm for 10 min to remove SN from the cells. The cells were then washed once at 1000 rpm/10 min and replated at 50,000 per well under the same culture conditions, but with different combinations of ligand or SN (or both) (phase 2). After 48 hr of additional culture, the cells were washed and the cell cycle status was determined by AO analysis.Lymphokines. Two sources of lymphokines were used: (i) the SN of Con A-pulsed PK 7.1 cells (13), which contains BCGF I (BSFpl) and BCGF II (14) but lacks interferon-y (IFN-y) and IL-2 (13), and (ii) a preparation of BSFpl purified by HPLC.Preparation of BSFpl. Partially purified BSFpl was prepared by a technique to be described in detail elsewhere (J. Ohara, S. Lahet, J. Inman, and W. E. Paul, personal communication) and was the generous gift of J. Ohara. Briefly, EL-4 cells were induced with phorbol 12-myristate 13-acetate (PMA) (10 ng/ml) in serum-free culture medium. The cell-free SN was harvested after 48 hr and incubated with trimethylsilyl-controlled pore glass beads (Sepralyte; Analytichem International, Harbor City, CA). The beads were Abbreviations: AO, acridine o...